The clinical course of follicular lymphoma

Best Practice and Research: Clinical Haematology

Volumn 18, Issue 1 SPEC. ISS., 2005, Pages 1-10

  Rohatiner, Ama Z S ^a   Lister, T Andrew ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Clinical course; Conventional treatment; Follicular lymphoma

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; PURINE DERIVATIVE; RITUXIMAB; VINCA ALKALOID; VINCRISTINE;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER CLASSIFICATION; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; FOLLICULAR LYMPHOMA; HUMAN; LYMPH NODE BIOPSY; MALIGNANT TRANSFORMATION; MEDICAL ASSESSMENT; NONHODGKIN LYMPHOMA; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 13344259296     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2004.06.002     Document Type: Review

References (76)

1. E. Becker Ein beitrag zur lehre von den lymphomen Deutsche Medizinishe Wchnschrift 27 1917 726-728
2. N.E. Brill G. Baehr & N. Rosenthal Generalised giant lymph follicle hyperplasia of lymph nodes and spleen. A hitherto undescribed type Journal of American Medical Association 2 1925 668-671
3. D. Symmers Giant follicular lymphadenopathy with or without splenomegaly Archives of Pathology 26 1938 603-647
4. E.A. Gall & T.B. Mallory Malignant lymphoma: A clinicopatholological survey of 618 cases American Journal of Pathology 18 1942 381-415
5. J. Armitage & D. Weisenburger New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic sub-types The Journal of Clinical Oncology 16 1998 2780-2795
6. National Cancer Institute Sponsored study of classification on non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage The Non-Hodgkin's Lymphoma Pathologic Classification Project Cancer 49 1982 2112-2135
7. C.J. Gallagher W.M. Gregory A.E. Jones et al. Follicular lymphoma: prognostic factors for response and survival The Journal of Clinical Oncology 4 1986 1470-1480
8. F.D. Groves M.S. Linet L.B. Travis et al. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995 Journal of National Cancer Institute 92 2000 1240-1251
9. J.J. Biagi & J.F. Seymour Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation Blood 99 2002 4265-4275
10. S.J. Horning & S.A. Rosenberg The natural history of initially untreated low-grade non-Hodgkin's lymphoma New England Journal of Medicine 311 1984 1471-1508
11. S. Soubeyran H. Eghbali F. Bonichon et al. Localised follicular lymphomas: Prognosis and survival of stages I and II in a retrospective series of 103 patients Radiotherapy and Oncology 13 1988 91-98
12. R. Taylor S. Allan M. McIntyre et al. Low grade stage I and II non-Hodgkin's lymphoma: Results of treatment and relapse pattern following therapy Clinical Radiology 39 1988 287-290
13. T. Lawrence W. Urba S. Steinberg et al. Retrospective analysis of Stage I and II indolent lymphomas at the National Cancer Institute International Journal of Radiation Oncology, Biology, Physics 14 1988 417-424
14. B. Vaughan Hudson G. Vaughan Hudson K. MacLennan et al. Clinical stage I non-Hodgkin's lymhoma: Long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy British Journal of Cancer 69 1994 1088-1093
15. S. Pendlebury M. el Awadi S. Ashley et al. Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma Radiotherapy and Oncology 36 1995 167-171
16. M. MacManus & R. Hoppe Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University The Journal of Clinical Oncology 14 1996 1282-1290
17. M. Gospodarowicz T. Lippuner M. Pintillie et al. Stage I and II follicular lymphoma: Long-term outcome and pattern of failure following treatment with involved field radiation therapy alone International Journal of Radiation Oncology, Biology, Physics 45 1999 217a
18. R.B. Wilder D. Jones S.L. Tucker et al. Long-term results with radiotherapy for Stage I-II follicular lymphomas International Journal of Radiation Oncology, Biology, Physics 51 2001 1219-1227
19. D.A.G. Galton L.G. Israels J.D.N. Nabarro et al. Clinical trial of p(di-chloroethylamino) phenylbutyric acid (CB 1348) in malignant lymphoma British Medical Journal 2 1955 1172
20. B. Hoogstraten A.H. Owens R.E. Lenhard et al. Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma Blood 33 1969 370
21. J.K. Luce J.F. Gamble H.E. Wilson et al. Combined cyclophosphamide, vincristine and prednisolone therapy of malignant lymphoma Cancer 28 1971 306
22. C.M. Bagley V.T. de Vita C.W. Berrard et al. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine and prednisolone Annals of Internal Medicine 76 1972 227
23. T.A. Lister M.H. Cullen M.E.J. Beard et al. Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological sub-type Brtish Medical Journal 1 1978 533
24. B.J. Kennedy C.D. Bloomfield D.T. Kiang et al. Combination versus successive single agent chemotherapy in lymphocytic lymphoma Cancer 41 1978 23
25. P.W.M. Johnson A.Z.S. Rohatiner J.S. Whelan et al. Patterns of survival in patients with recurrent follicular lymphoma: A 20 year study from a single centre The Journal of Clinical Oncology 13 1995 140-147
26. A. Rohatiner P. Johnson C. Price et al. Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma The Journal of Clinical Oncology 12 1994 1177
27. Y. Bastion P. Brice C. Haioun et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor prognosis follicular lymphoma Blood 86 1995 3257
28. R. Haas M. Moos R. Mohle et al. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma Bone Marrow Transplantation 17 1996 149
29. J. Apostolidis J. Foran P. Johnson et al. Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow support for follicular lymphoma The Journal of Clinical Oncology 17 1999 216
30. A.R. Freedman D. Neuberg P. Mauch et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma Blood 94 1999 3325
31. J. Apostolidis R.K. Gupta D. Grenzelias et al. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long term clinical and molecular follow-up The Journal of Clinical Oncology 18 2000 527
32. S.J. Horning R.S. Negrin R.T. Hoppe et al. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: Results of a phase II clinical trial Blood 97 2001 404
33. H.C. Schouten W. Olan S. Kvaloy et al. High-dose therapy improves progression-free survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomised European CUP trial The Journal of Clinical Oncology 21 2003 3918-3927
34. D.G. Maloney T.M. Liles D.K. Czerwinski et al. Phase I clinical trial using escalating single dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma Blood 84 1994 2457
35. P. McLaughlin A.J. Grillo-Lopez B.K. Link et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program The Journal of Clinical Oncology 16 1998 2825
36. J.M. Foran R.K. Gupta D. Cunningham A U.K. et al. A multicentre Phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) in patients with follicular lymphoma, with PCR monitoring of molecular response British Journal of Haematology 109 2000 81
37. P. McLaughlin F.B. Hagemeister J.E. Romaguera et al. Fludarabine, mitoxantrone and dexamethasone: An effective new regimen for indolent lymphoma The Journal of Clinical Oncology 14 1996 1262-1268
38. P.L. Zinzani M. Bendandi M. Magagnoli et al. Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma Annals of Oncology 8 1997 379-383
39. C.R. Crawley J.M. Foran R.K. Gupta et al. A phase II study to evaluate the combination of fludarabine, mitoxantrone and dexamethasone (FMD) in patients with follicular lymphoma Annals of Oncology 11 2000 861-865
40. 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: Updated results and long-term follow-up of the University of Michigan experience Blood 96 2000 1259-1266
41. 131I tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas The Journal of Clinical Oncology 18 2000 1316-1323
42. 131I tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas The Journal of Clinical Oncology 19 2001 3918-3928
43. 90yttrium-labelled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade follicular, or transformed B-cell non-Hodgkin's lymphoma The Journal of Clinical Oncology 20 2002 2453-2463
44. G.A. Wiseman L.I. Gordon P.S. Multani et al. Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin's lymphoma and mild thrombocytopenia: A phase II multicenter trial Blood 99 2002 4336-4342
45. T.E. Witzig Gordon L.I. Flinn IV et al. Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma The Journal of Clinical Oncology 20 2002 3262-3269
46. I.F. Khouri R.M. Saliba S.A. Giralt et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: Low incidence of toxicity, acute graft-versus-hose disease, and treatment-related mortality Blood 98 2001 3595-3599
47. V.I. Pappa H.K. Hussain R.H. Reznek et al. The role of image-guided core needle biopsy in the management of patients with lymphoma The Journal of Clinical Oncology 14 1996 2427-2430
48. A. Yuen O. Kamel J. Halpern et al. Long-term survival after histologic transformation of low-grade follicular lymphoma The Journal of Clinical Oncology 13 1995 1726-1733
49. Y. Bastion C. Sebban F. Berger et al. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients The Journal of Clinical Oncology 15 1997 1587-1594
50. B. Acker R.T. Hoppe T.V. Colby et al. Histologic conversion in the non-Hodgkin's lymphomas The Journal of Clinical Oncology 1 1983 11-16
51. J.O. Armitage F.R. Dick & M.P. Corder Diffuse histocytic lymphoma after histologic conversion: A poor prognostic variant Cancer Treatment Reports 65 1981 413-418
52. S.M. Hubbard B.A. Chabner V.T. DeVita et al. Histologic progression in non-Hodgkin's lymphoma Blood 59 1982 258-264
53. M.H. Cullen T.A. Lister R.L. Brearly et al. Histological transformation of non-Hodgkin's lymphoma: A prospective study Cancer 44 1979 645-651
54. J. Ersboll H.B. Schultz J. Pedersen-Bjergaard et al. Follicular low-grade non-Hodgkin's lymphoma: Long term outcome with or without tumor progression European Journal of Haematology 42 1989 155
55. S.S. Ostrow C.H. Diggs J.C. Sutherland et al. Nodular poorly differentiated lymphocytic lymphoma: Changes in histology and survival Cancer Treatment Reports 65 1981 929
56. A.R. Yuen & S.J. Horning Long term survival after histologic transformation of low grade lymphoma Proceedings of the American Society of Clinical Oncology 12 1993 365 [Abstract 1236].
57. J.M. Foran J. Apostolidis D. Papamichael et al. High dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: A study of 27 patients from a single centre Annals of Oncology 9 1998 865-869
58. J. Friedberg D. Neuberg J. Gribben et al. Autologous bone marrow transplantation following histologic transformation of indolent B-cell malignancies Biology of Blood and Marrow Transplantation 5 1999 262-268
59. C.D. Williams C.N. Harrison T.A. Lister et al. High-dose therapy and autologous stem cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: A case matched study from the European Bone Marrow Transplant Registry The Journal of Clinical Oncology 19 2001 727-735
60. C.I. Chen M. Crump R. Tsang et al. Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma British Journal of Haematology 113 2001 202-208
61. P. Brice Y. Bastion E. Lepage et al. Comparison in low-tumour-burden follicular lymphomas between an initial no-treatment policy, prednimustine or interferon-alpha: A randomised study from the Groupe d'Etude des Lymphomes Folliculaires The Journal of Clinical Oncology 15 1997 1110
62. M.E. O'Brien P. Easterbrook J. Powell et al. The natural history of low-grade non-Hodgkin's lymphomas and the impact of a no initial treatment policy on survival Quarterly Journal of Medicine 80 1991 651-660
63. R.C. Young D.L. Longo E. Glatstein et al. Watchful waiting versus aggressive combined modality treatment Seminars in Hematology 11 1988 6
64. K.M. Ardeshna P. Smith A. Norton et al. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced stage non-Hodgkin's lymphoma: A randomised controlled trial Lancet 362 2003 516-522
65. C.S. Portlock & S.A. Rosenberg No initial therapy for stage III and IV non-Hodgkin's lymphomas of favourable histologic types Annals of Internal Medicine 90 1979 10-13
66. R. Advani S.A. Rosenberg & S.J. Horning Stage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy The Journal of Clinical Oncology 22 2004 1454-1459
67. S.J. Horning Natural history of and therapy for the indolent non-Hodgkin's lymphomas Seminars in Oncology 20 1993 75-88
68. S.J. Horning Follicular lymphoma: Have we made any progress? Annals of Oncology 11 2000 23-27
69. J. Romaguera P. McLaughlin L. North et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphomas: A risk model The Journal of Clinical Oncology 9 1991 762-769
70. M. Frederico U. Vitolo P. Zinzani et al. Prognosis of follicular lymphoma: A predictive model based on a retrospective analysis of 987 cases Blood 95 2000 783-789
71. D. Decaudin E. Lepage N. Brousse et al. Low-grade stage III-IV follicular lymphoma: Multivariate analysis of prognostic factors in 484 patients-a study of the Groupe d'Etude des Lymphomes de l'Adulte The Journal of Clinical Oncology 17 1999 2499-2505
72. Anon A predictive model for aggressive non-Hodgkin's lymphoma. The International non-Hodgkin's Lymphoma Prognostic Factors Project New England Journal of Medicine 329 1993 987-994
73. A. Lopez-Guillermo E. Montserrat F. Bosch et al. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphomas The Journal of Clinical Oncology 12 1994 1343-1348
74. P. Solal-Celigny P. Roy P. Colombat et al. Follicular Lymphoma International Prognostic Index Blood 2004 (in press)
75. S. Montoto A. Lopez-Guillermo A. Ferrer et al. Survival after progression in patients with follicular lymphoma: Analysis of prognostic factors Annals of Oncology 13 2002 523-530
76. Q. Liu L. Fayad F.B. Hagemeister et al. Stage IV Indolent lymphoma: 25 years of treatment progress Blood 102 2003 1446a